Elimination of residual adult T‐cell leukaemia clones by Tax‐targeted dendritic cell vaccine
Abstract Background A pilot clinical study of a Tax peptide‐pulsed dendritic cell (DC) vaccine for adult T‐cell leukaemia/lymphoma (ATL) indicated favourable clinical outcomes. Methods We investigated its anti‐tumour effect by T cell receptor (TCR) repertoire analysis in samples from an enrolled ATL...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-02-01
|
| Series: | eJHaem |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jha2.1072 |